Question 1

Who are the top researchers at Redx Pharma (United Kingdom)?

Accepted Answer

Ranked on the quality score, Simon A. Woodcock, Peter Bunyard and Neil R. Stokes lead among researchers whose main affiliation is Redx Pharma (United Kingdom).

Question 2

What are the most cited papers from Redx Pharma (United Kingdom)?

Accepted Answer

The most cited paper from Redx Pharma (United Kingdom) is "Cross-validation pitfalls when selecting and assessing regression and classification models" (Damjan Krstajić, Ljubomir J. Buturović, David E. Leahy et al., 2014), with 1,115 citations. Next come "Standardization of test conditions for high performance liquid chromatography columns" (523) and "Immunohistochemical localisation of urogastrone to human duodenal and submandibular glands." (201).

Question 3

Which research topics does Redx Pharma (United Kingdom) publish most on?

Accepted Answer

By volume in 2022-now: Cancer Mechanisms and Therapy, Diabetes Treatment and Management, Phosphodiesterase function and regulation and Coagulation, Bradykinin, Polyphosphates, and Angioedema.

Question 4

Which keywords describe research at Redx Pharma (United Kingdom)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Therapy, Cancer Progression, Oxidative Stress, Cancer, Cell Signaling, Clinical Trials, Phosphorylation and Therapeutic Targets.

Question 5

Which fields of science does Redx Pharma (United Kingdom) work in?

Accepted Answer

In 2022-now, 48% of research at Redx Pharma (United Kingdom) is in Health Sciences, 36% in Life Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (31%), Social Sciences (3%). It does 1.9× the world's share of Life Sciences.

Question 6

Is Redx Pharma (United Kingdom)'s research output growing?

Accepted Answer

Output in 2022-2025 was 55% higher than in 2018-2021.